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Abstract
Background: There is some evidence that electroencephalography
guidance of general anesthesia can decrease postoperative delirium after
non-cardiac surgery. There is limited evidence in this regard for cardiac
surgery. A suppressed electroencephalogram pattern, occurring with deep
anesthesia, is associated with increased incidence of postoperative
delirium (POD) and death. However, it is not yet clear whether this
electroencephalographic pattern reflects an underlying vulnerability
associated with increased incidence of delirium and mortality, or whether it
is a modifiable risk factor for these adverse outcomes.
Methods: The Electroencephalography Guidance of Anesthesia to
Alleviate Geriatric Syndromes (ENGAGES-Canada) is an ongoing
pragmatic 1200 patient trial at four Canadian sites. The study compares
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the effect of two anesthetic management approaches on the incidence of
POD after cardiac surgery. One approach is based on current standard
anesthetic practice and the other on electroencephalography guidance to
reduce POD. In the guided arm, clinicians are encouraged to decrease
anesthetic administration, primarily if there is electroencephalogram
suppression and secondarily if the EEG index is lower than the
manufacturers recommended value (bispectral index (BIS) or WAVcns
below 40 or Patient State Index below 25). The aim in the guided group is
to administer the minimum concentration of anesthetic considered safe for
individual patients. The primary outcome of the study is the incidence of
POD, detected using the confusion assessment method or the confusion
assessment method for the intensive care unit; coupled with structured
delirium chart review. Secondary outcomes include unexpected
intraoperative movement, awareness, length of intensive care unit and
hospital stay, delirium severity and duration, quality of life, falls, and
predictors and outcomes of perioperative distress and dissociation.
Discussion: The ENGAGES-Canada trial will help to clarify whether or not
using the electroencephalogram to guide anesthetic administration during
cardiac surgery decreases the incidence, severity, and duration of POD.
Registration: ClinicalTrials.gov (NCT02692300) 26/02/2016

Any reports and responses or comments on the
article can be found at the end of the article.
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Background
Delirium and cardiac surgery
Postoperative delirium (POD) is an acute and typically
reversible syndrome, characterized by a fluctuating level of
consciousness and disturbances in attention and cognition1.
Patients undergoing cardiac surgery are at especially high risk of
developing POD2–9. The incidence of POD after cardiac surgery is estimated to be between 20% and 70% depending on the
population studied and the methods used to assess delirium2–9.
Delirium has been described either as hyperactive or hypoactive, the latter being more difficult to diagnose in the clinical
setting than the former1. As one of the most common complications after cardiac surgery in older adults, POD is associated with
prolonged length of hospital and intensive care unit (ICU)
stay, increased morbidity and mortality, functional and cognitive decline, and is often associated with placement in long-term
care facility6,7,10.
Several non-modifiable risk factors at the time of surgery are
associated with POD including age 60 years and older, preexisting cognitive impairment, psychiatric comorbidities, and
low baseline regional cerebral oxygen saturation8,9,11–13. Possible precipitating risk factors specific to cardiac surgery include
the type of cardiac surgery, cardiopulmonary bypass time, and
the number of blood product transfusions7,9. The identification
of potentially modifiable perioperative risk factors, for example relating to the conduct of general anesthesia for cardiac
surgery7, could positively impact this major health issue.

Electroencephalogram guided anesthetic management and
delirium
While the use of processed electroencephalogram (EEG) indices to monitor depth of anesthesia is relatively prevalent in the
anesthesiology community, these have mainly been directed
towards avoiding patient awareness during surgery14–16. Recent
interest has shifted to the potential for intraoperative EEG
monitoring to prevent postoperative delirium17,18. The notion is that
there might be specific EEG patterns that are strongly associated
with POD, and these can be avoided through alterations in anesthetic management. One of these patterns is burst suppression,
which is characterized by an isoelectric or suppressed EEG pattern followed by a short burst of high amplitude activity. Burst
suppression is considered to be “a strong synchronized outflow of thalamic discharges to a widely unresponsive cortex”19.
Burst suppression is not encountered in normal physiological
conditions such as sleep, but is associated with coma, induced
hypothermia, some forms of epilepsy, cerebral hypoxia,
and deep general anesthesia20. Both the occurrence of burst
suppression and the cumulative duration of EEG suppression
during general anesthesia have been associated with POD, but
without clear evidence for causality3,21,22. The risk for burst suppression during general anesthesia might be increased by older
age, medical comorbidities, a greater intraoperative dose of
benzodiazepines, and, most importantly, increased intraoperative
volatile or intravenous anesthetic concentration3,21. The combination of EEG suppression and hypotension has been associated
with increased mortality at 90 days post-surgery23. We therefore
hypothesized that intraoperative guidance of anesthesia with
the aim of avoiding or minimizing EEG suppression could

decrease the incidence of POD in cardiac surgery patients. Evidence for this hypothesis is bolstered by recently published
meta-analyses of randomized trials, which reported that using
a processed EEG monitor to guide anesthetic administration is
likely to substantially decrease the incidence of POD7,24,25. While
a recent randomized controlled trial using a strategy to avoid
EEG suppression in older adults undergoing major surgery
was not shown to be effective in decreasing the incidence of
POD26, this strategy has not been tested specifically in older
cardiac surgery patients, a population with many risk factors
and a high incidence of POD.

The ENGAGES-Canada study: potential impact
The intent of the ENGAGES-Canada study is to determine if
EEG-guided anesthesia to reduce anesthetic agent administration,
thereby minimizing episodes and durations of EEG suppression, can effectively decrease the incidence of POD and its
downstream sequelae in patients undergoing cardiac surgery
(Table 1). The approach of minimizing periods of EEG suppression specifically during cardiac anesthesia has not been
previously tested in a large clinical trial. Recently published
meta-analyses have suggested that EEG guidance of anesthesia decreases the incidence of POD by more than a third25. If
this result is reproduced in subsequent rigorous clinical trials,
it will have important implications for how anesthesia is
administered – especially to older adults. On the other hand,
premature implementation based on the existing preliminary
evidence might have unintended negative consequences. It is
within this context that the ENGAGES trial and ENGAGESCanada will provide critically clarifying information27,28. The
ENGAGES trial addressed the question in unselected older
adults undergoing major surgery26. ENGAGES-Canada will
address the question specifically in cardiac surgery patients,
where the risk of POD is especially high2–9.
Thus, the objective of the ENGAGES-Canada trial is to address
whether reducing anesthetic administration based on EEG information during cardiac surgery primarily decreases the incidence
of POD, and secondarily decreases the duration and severity
of POD. Other relevant measures in the trial will be clinically
relevant outcomes determined at the index hospitalization, at
approximately 30-day postoperatively, and at approximately
1-year postoperatively.

Methods
Overview of the research design and study subjects
The Research Ethics Boards of the Montreal Heart Institute
(2017-2164), the University of Manitoba (HS18290), Kingston
University (ANAE-298-16), and the University of Toronto
(17-5933) all approved the study. The details of the design of
the ENGAGES-Canada study are included in this protocol and it
contains the complete list of elements from the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials)
checklist29,30. This study was registered with ClinicalTrials.gov
(NCT02692300) on 26 February 2016.
The ENGAGES-Canada will randomize 1200 patients of 60
years old and older in a clinical trial designed to be pragmatic. The first patient randomized in the trial was enrolled in
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Table 1. ENGAGES-Canada: Conceptualization – Intervention, Mediators, Outcomes, and Adverse Events. Assessment acronyms:
EEG – Electroencephalogram; ICU – Intensive Care Unit.
ENGAGES-Canada: Conceptualization
Intervention

·EEG-guided reduction of anesthesia

Mediators

·Intraoperative mediators
    ○Decrease in EEG suppression
    ○Decrease in anesthetic exposure
    ○Decrease in hypotension

• Hypothetically linked both to the intervention as well
as to the outcomes and the adverse events
Primary Outcome

·Incident postoperative delirium

Exploratory Secondary Outcomes

·Length hospital and ICU of stay

Other Exploratory Outcomes

·Postoperative falls incidence and association between delirium and falls
·Delirium duration and severity
·Postoperative quality of life
·Perioperative distress and dissociation ·Other delirium outcomes: delirium on
day 0, time to delirium onset, sensitivity analyses, covariate adjustment
· intraoperative mediating events: anesthetic concentrations,
electroencephalogram suppression time and hypotension duration
·Functionality
·Cognition

Major Perioperative Adverse Events

·Undesirable movement
·Awareness with recall
·Serious complications (examples: major blood loss and transfusions, stroke,
sternal wound infection, sepsis, dialysis, prolonged intubation)
·Death

November 2016. Competent patients who provide informed
consent and who are undergoing elective cardiac surgery with
cardiopulmonary bypass are eligible to be included in the study.
There are no absolute contraindications to EEG monitoring,
and the design of the ENGAGES-Canada trial is largely pragmatic. Exclusion criteria include positive preoperative delirium
screening. In addition, patients with hearing impairment, and
those who are blind, illiterate, or do not speak French or English will be excluded because they will not be able to participate
adequately in delirium screening. Finally, patients who have
previously had general anesthesia and who have reported
experiencing intraoperative awareness will also be excluded31.
Participants are randomized to either one of two groups: in the
guided group, anesthetic administration is guided largely by
EEG waveform; in the other group, patients receive current
usual anesthetic care for cardiac surgery. Delirium and other
assessments take place preoperatively, and delirium is assessed
postoperatively from day one to five while the patient is in the
hospital. The primary outcome will be the incidence of
postoperative delirium. As secondary and other outcomes, we
will also examine stress reaction and dissociation at discharge
as potential factors associated with delirium and predictors of
postoperative psychiatric symptoms. At 30-days and at 1-year,
follow-up assessments include the quality of life as related to
health, cognitive functioning, and information on psychiatric
symptoms and on the incidence of falls – collected via self-report.

Recruitment
All patients in the study are asked to sign an informed consent
(see extended data32). Subjects are recruited through the PreAnesthesia Clinics, and baseline questionnaires are given at that
time if they agree to participate. Perioperative clinics are staffed
with anesthesiologists and nurses specialized in perioperative medicine to evaluate the perioperative risks of each patient.
Patients can also be enrolled prior to surgery in hospital
wards during the preoperative visit.
Based on data from previous clinical trials including those focused
exclusively on cardiac surgery2,8, we expect the study population
to be largely balanced based on sex and there is no stratification
of randomization by sex. Older and more vulnerable patients
are often under-represented in clinical research. The patients
enrolled in the trial should constitute a broad representation
of older adults undergoing cardiac surgery in Canada.

Randomization and blinding
Computer-generated assignment at the patient level is used
for randomization. Patients who are eligible, and have given
informed consent, are randomized to either usual care or to the
protocol for guided anesthesia according to the EEG. A one
to one ratio of randomization of the patients between usual
care and the protocol for EEG-guidance is used. Within the
research team, members are trained to enroll participants and
assign the randomization between the usual care or the protocol
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for EEG-guidance. Anesthesiologists and their team learn of the
group assignment after the patient is brought into the operating room; an opaque, sequentially numbered, sealed envelope is opened to reveal the study group. The randomization
sequence is generated by the data analysis center. The anesthesiologist and the team caring for the patient intraoperatively are
not blinded to the group assignment. The patients and family
members are not aware of the group assignment. The research
team members who are in charge of the assessment of delirium postoperatively remain blinded to the group assignment.
Chart reviews are conducted by individuals blinded to the
group assignment and blinded to the outcome of the postoperative delirium assessments29,30. Predictability of the randomization sequence is minimized by recording in a separate
document, unavailable to the members of the research team who
enroll participants and assign groups, the details of patients
who have already been randomized.

Protocol for EEG-guided anesthesia
Patients randomized to the EEG-guided group undergo
anesthesia based on a pragmatic protocol to guide anesthesia
administration according to EEG information. Prior to study
participation, anesthesiologists are trained to recognize the
typical EEG patterns of the different levels of anesthesia seen
during anesthesia with volatile anesthetic agents; from the
pattern in awake patients to the pattern typically found during general anesthesia. Practitioners are also encouraged to
complete the online training provided on the website www.
anesthesiaEEG.com as well as to watch two educational modules on the website www.icetap.org: one on waveforms of
EEG and depth of anesthesia, and the other on Clinical decision making in anesthesia using the EEG. For sites using BIS
processed electroencephalogram monitors, the proprietary processed BIS value is used in the EEG-guided group for the trial,
as well as the raw waveforms of the EEG and all the numerical values seen on the monitor that are non-proprietary. These
include the spectral edge frequency and the burst suppression ratio. For sites using a SedLine® monitor, the processed
Patient State Index (PSi) in the EEG-guided group is used as
well as the raw EEG waveform, spectrograms and suppression
ratio. For sites using the NeuroSENSE® monitor, the processed
WAVcns in the EEG-guided group is used as well as the raw
EEG waveform, spectrograms and suppression ratio. To see
clearly the low frequency slow delta waves, the EEG filter
is turned off. If there is too much artifact in the EEG signal,
practitioners may intermittently turn on the EEG filter to
improve the resolution of the EEG trace. The anesthesiologists and their team are advised to inspect the waveform of the
EEG to detect when there are periods of EEG suppression. EEG
suppression can usually be recognized easily, and this pattern
represents the main trigger, according to the protocol, for
decreasing anesthetic administration. The low alarm is set at a
value of 40 on the BIS monitor and NeuroSENSE® monitor or
25 on the SedLine® monitor. The sounding of this low alarm
indicates an increased risk of a burst suppression pattern on
the EEG (see PSI 25-50 white paper)33. EEG index values less
than manufactures’ recommendations (BIS and WAVcns values
less than 40 or a PSi less than 25) indicate a second trigger for
decreasing the administration of anesthetic agents. It is important

to remember that the protocol of guidance of anesthesia
according to the EEG waveform is suggestive and not prescriptive. Clinical judgment can inform deviations from the
protocol according to the specific situations encountered. For all
patients, regardless of the allocation group, the low volatile alarm
(0.3 minimum alveolar concentration or clinician’s discretion)
sounds to decrease the risk of intraoperative awareness. In the
usual care group, the EEG monitor values are masked from the
anesthesia team, except for the signal quality measures, and
the data are stored for analysis of epochs of EEG suppression.
For sites using the BIS monitors and NeuroSENSE® monitors,
anesthesiologists see the signal quality index (SQI) only and
for sites using the SedLine® monitor practitioners only see the
impedance quality of the electrodes.

Anesthesiologists fidelity to the EEG-guided anesthetic
protocol
Monitoring devices can only influence and change clinical practice if important and useful information can be used by clinicians to make decisions regarding patient treatment during a
case. Motivation to make decisions and act upon data from a
monitoring device relies on familiarity with the device as well
as evidence relating to outcomes. The use of EEG guidance
of anesthesia in clinical practice is limited by the fact that electroencephalography is not formally part of the current residency
curriculum. It is therefore not surprising that EEG guidance of
anesthesia has not been adopted into usual anesthetic care.
Focused training sessions have shown that anesthesiologists
can readily learn the changes in EEG waveform associated
with sedation and general anesthesia34. Clinicians are capable of integrating the information from the EEG waveform
when provided with clinical context and of estimating the BIS
values associated with specific EEG waveforms34. Arising from
the results of this study, an international non-profit initiative
focused on EEG education was launched: International Consortium for Electroencephalograph Training of Anesthesia
Practitioners.
Teaching the EEG waveform to anesthesiologists at our institutions and emphasizing the role of EEG in the guidance of anesthetic management are crucial ingredients to the success of the
ENGAGES-Canada study. EEG derived parameters are captured
electronically. This includes both the proprietary values, such as
the BIS, WAVcns and PSi values, and non-proprietary values
such as the suppression ratio. As a proof of concept, we were
able to show in the first 102 patients enrolled to the ENGAGESCanada trial that there was a reduction in both cumulative EEG
suppression time and volatile anesthetic administration in the
patients randomized to EEG-guided anesthetic care. Since
our fundamental hypothesis for the ENGAGES-Canada study
is that, in real-world practice, alterations in the management of anesthesia guided by the EEG waveform can prevent
postoperative delirium, a crucial step was to confirm the ability of cardiac anesthesiologists to decrease the duration of EEG
suppression by following the EEG-guided protocol.

Outcomes
The primary outcome is the occurrence of incident delirium on
postoperative days 1-5. Secondary outcomes include: length of
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ICU and hospital stay; duration and severity of delirium POD
1-5; incidence of falls and association between delirium and
falls at 30 days and at 1 year; association between delirium and
quality of life by PROMIS Global Health; predictors of PostTraumatic Stress Disorder (PTSD) by PDEQ at 5 days and 30
days postoperatively; and predictors of Post-Traumatic Stress
Disorder (PTSD) by PDEQ at 5 days and 30 days postoperatively. Exploratory outcomes include co-variates of delirium,
functionality, and cognitive impairment at 30 days and at 1 year
postoperatively. Pre-specified exploratory analyses include intraoperative mediating events such as anesthetic concentrations,
electroencephalogram suppression time, and hypotension
duration. Perioperative adverse events include undesirable intraoperative movement, awareness with recall, complications
such as major blood loss and transfusions, stroke, sternal wound
infection, sepsis, dialysis, prolonged intubation, and mortality
rates at 30-day and at 1-year.

Data collection
Preoperative
Preoperative assessments are performed in the Pre-Anesthesia
Clinic or hospital ward. These include demographic information and medical history, assessment of preoperative quality of
life, psychiatric symptoms (i.e., anxiety, depression, alcohol use,
trauma history, and posttraumatic stress disorder), objective and
subjective cognitive functioning measures35,36, and evaluation
of falls’ history. The purpose of the preoperative assessments
is to identify cognitive and psychiatric disorders in order to
better understand risk factors for postoperative delirium and its
sequelae. For example, postoperative delirium has been associated with impaired performance on preoperative cognitive
tests37, and postoperative delirium predicts persistent postoperative cognitive decline6. These known risk factors will be
included in covariate analysis for the primary outcome and
will be used in exploratory analyses. The following measures
were selected for the assessment of cognitive and psychiatric symptoms based on their brevity, frequency of use in medical practice, validity for older adults, and lack of copyright
restrictions: (1) 8-item AD8 Dementia Screen38, (2) History of
Delirium Screen, (3) Short Blessed Test39, (4) 3-item Alcohol
Use Disorders Identification Test (AUDIT-C), (5) 1-item surgical anxiety visual analogue scale, (6) Trauma History Screen,
(7) Posttraumatic Stress Disorder Checklist (PCL-5; past-month
PTSD assessment), (8) 4-item Primary Care PTSD Screen
(PC-PTSD; lifetime PTSD assessment), (9) 4-item Patient
Health Questionnaire (PHQ-4; anxiety and depressive symptoms), (10) 10-item Patient Reported Outcomes Measurement Information System (PROMIS) Global Health (physical
and mental health related quality of life), (11) 4-item PROMIS
Applied Cognition-Cognitive Concerns, (12) 4-item PROMIS
Applied Cognition-Abilities (see extended data32). Patients will
also receive a questionnaire regarding history of falls. Baseline
screening, informed consent, delirium assessments (described
below), and self-report symptom measures take approximately
30-40 minutes. Research assistants obtain informed consent and
administer AD8 Dementia Screen, History of Delirium Screen,
Confusion Assessment Method (CAM long form; detailed below),
and the Short Blessed Test; the remaining surveys can be completed independently if the patient has the capacity to do so. A

script is provided to research assistants to introduce the psychiatric symptom measures (extended data32). If patients request a
direct referral for mental health related issues, they are referred
to the appropriate clinician by the attending anesthesiologist
in the Pre-Anesthesia Clinic.

Perioperative period (up until discharge)
Delirium and pain are assessed postoperatively in the afternoon/
evening while patients are in the hospital. Daily delirium assessments collected specifically for the ENGAGES-Canada study
are entered into the Washington University School of Medicine
Research Electronic Data Capture (REDCap)40 database. EEG
data, including BIS values, WAVcns, PSi values, and duration of
EEG burst suppression are collected in both the guided as well as
in the usual care group. In the usual care group, anesthesiologists are blinded to EEG data41,42. Perioperative data, including the repeated measures data, are saved for analysis from the
intraoperative electronic data capture. As part of the routine
data collection, we obtain for each patient a detailed medical
history, surgical history, specific risk factors, medications,
Blessed Dementia rating scale, screening for sleep apnea,
laboratory values, medications during surgery, physiological
readings, and parameters from the postoperative recovery
period. At the time of discharge, patients will also complete a
measure of immediate stress reactions (13-item Peritraumatic
Distress Inventory; PDI) and peritraumatic dissociation (10-item
Peritraumatic Dissociative Experiences Questionnaire; PDEQ)
in the perioperative period, which have been found to be strong
predictors of incident psychiatric disorders immediately following
the stressful experience. Furthermore, they will complete an
adapted 4-item PHQ-4 concerning more general anxiety and
depressive symptoms, specifically during the perioperative period.
These tests take patients approximately 5 minutes in addition
to their CAM long form assessment (10 minutes).
Postoperative delirium
The primary outcome of the study is the incidence of postoperative delirium. Assessment of postoperative delirium is
conducted in patients that can be sufficiently aroused according
to a Richmond Agitation and Sedation Score ≥ -3. Assessment
of patients for delirium is performed from day one to day 5,
once daily, in the afternoon/evening. A diagnosis of delirium
for each patient is based on an approach combining a standardized daily assessment with a structured chart review. Members
of the research team who are blinded to the treatment arm
of the study assess patients for delirium using the Confusion
Assessment Method (CAM long form)43, or the Confusion
Assessment Method for the Intensive Care Unit (CAM-ICU)44,45
for patients who are unable to speak (e.g., have a tracheal tube
or tracheostomy). The CAM long form is deemed a viable tool
that can be used by non-psychiatrists and by non-mental health
professionals for delirium detection43. The CAM long form
has subsequently been validated in a number of studies and
against a reference standard, with a sensitivity of >94% and a
specificity of >89%46. The CAM long form and the CAM-ICU
are reliable instruments in good agreement with the DSM-IV
criteria for delirium45,47,48. To complete the delirium assessment of patients, a trained clinical researcher blinded to the
CAM results and group assignment conducts a structured chart
Page 6 of 16

F1000Research 2019, 8:1165 Last updated: 24 SEP 2019

reviews for delirium detection. A positive CAM long form, or
CAM-ICU, or chart review delirium detection49,50 is deemed
sufficient and necessary to diagnose incident delirium in the
ENGAGES-Canada trial. The approach combining a CAM long
form interview, or a CAM-ICU, plus a chart review results in an
increase in the sensitivity while retaining specificity in detecting incident delirium49,50. In addition, use of a chart review
bolsters the pragmatic aspects of this trial, since it obtains information from a readily available source. Determination of delirium severity is based on the CAM-S long form measure or the
CAM-ICU-7 Delirium severity instrument51,52.
The CAM long form assessment that is used in the trial was
developed by Dr. Inouye and colleagues43, and includes a brief
cognitive battery. All study team members who perform delirium assessments undergo a structured training process. For the
initial training, representatives from the research team participated in a full-day training program led by Dr. Inouye, the original
creator of the CAM long form53. Those who attended this
initial training are overseeing the training of other team members. Trainees must demonstrate competence at both conducting CAM long form and CAM-ICU interviews and in scoring
these interviews. To establish their ability to score CAM long
form interviews, trainees accompany trained team members to
conduct CAM long form interviews. A trained member of the
research team conducts each CAM long form interview for
patients enrolled in the trial. The trainee observes the interview, but scores the CAM long form independently. The
trainee must agree with the trainer on the presence or absence
of all 12 cognitive features assessed by the CAM long form
on a minimum of two delirious and two non-delirious patients.
After meeting the stipulations of training, the newly trained team
member will conduct their first interview of a patient enrolled
into the trial in the presence of a previously trained team
member. Independently of the training, all team members
who are participating in CAM long form assessments must
view and rate nine videos of standard interviews of actors
depicting delirious and non-delirious patients. Research team
members must be trained on CAM long form assessments prior to
completing any structured delirium chart reviews.
This structured process is employed to evaluate and confirm the
quality of the assessments of delirium. In all cases the assessments of delirium are reviewed within three days by a fellow
member of the research team to evaluate internal consistency
of scoring and completeness. Once a month, all challenging
delirium assessments are discussed in a conference call including investigators from all sites. Whenever there is ongoing
disagreement regarding a CAM long form, CAM-ICU or delirium chart review, these are allocated to experts for adjudication
(involving ES, SI). Ongoing interrater-reliability assessments
of all study staff are planned annually. A random selection
of CAM long form, CAM-ICU, and structured chart reviews
are sent to experts for quality control purposes.

30-days postoperative
Self-report psychiatric and cognitive symptom measures are
either mailed to patients 30-days post-surgery with a stamped

and addressed return envelope, sent by e-mail, or obtained
through a telephone call. The following measures are re-administered: Falls Questionnaire, AUDIT-C, PDEQ, PCL-5, PHQ-4,
PROMIS Global Health, PROMIS Applied Cognition-General
Concerns, and PROMIS Applied Cognition-Cognitive Abilities.
These tests take approximately 15 minutes for patients to
complete.

1-year postoperative
Self-report psychiatric and cognitive symptom measures are
either mailed to patients 1-year post-surgery with a stamped and
addressed return envelope, sent by e-mail, or obtained through
a telephone call. The following measures are re-administered:
Falls Questionnaire, AUDIT-C, PCL-5, PHQ-4, PROMIS
Global Health, PROMIS Applied Cognition-General Concerns,
and PROMIS Applied Cognition-Cognitive Abilities. Additionally, patients are contacted via phone and receive the Short
Blessed Test. These tests take patients approximately 15 minutes
to complete by writing. The phone call for the Short Blessed Test
lasts approximately 3 minutes.
Sample size calculation statistical analyses
Based on previous studies in cardiac surgery patients, we conservatively estimated a delirium incidence in the control group
of 25%2–9 and based on meta-analyses of randomized trials
we estimated a relative reduction in delirium with guidance of
anesthesia based on EEG waveform of more than one-third3,7,24.
Assuming a two-sided alpha <0.05 and 1200 patients, we
estimated >90% power to be able to detect an absolute decrease
in the incidence of delirium of 8%27. With a more stringent
two-sided alpha <0.005, we estimated >70% power. We anticipate that most patients will be available for primary outcome
ascertainment (i.e. incident postoperative delirium assessment).
Continuous variables will be presented as mean (SD) or median
(interquartile range [IQR]), depending on their distributions.
Chi-square or Fisher’s exact tests will be used for comparisons of discrete data. Unpaired Student’s t or Mann–Whitney
U tests will be used for comparisons of continuous data, depending on their distributions. Confidence intervals for median differences will be calculated using Hodges-Lehmann estimates,
and for differences between proportions we will use Newcombe’s method with continuity correction54. For the primary
outcome, the proportion of patients with incident postoperative
delirium will be compared between the two study groups. We
will conduct three post-hoc sensitivity analyses to assess whether
improved clinician fidelity to the guided protocol might alter the
primary outcome. Within the guided group 25% of cases will
be excluded with the (1) longest cumulative electroencephalogram suppression time; (2) longest cumulative time with
BIS, WAVcns <40 or PSi <25; and (3) highest median volatile
anesthetic concentrations. To compare time to delirium onset
between groups, we will construct Kaplan-Meier curves for each
group and conduct a log-rank test. We will perform a covariate
adjustment including likely risk factors for delirium (including
age, sex, history of depression, history of delirium, AD* Test,
Short Blessed Test, comorbidity index, and study center) using
two methods: (1) logistic regression and (2) standardized
estimator combined with bootstrapped 95% confidence intervals
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(CIs)55. We will compare delirium incidence between groups,
segregated by Charlson Comorbidity Index categories56.
Patients will be assessed based on their randomization group in
accordance with an intention-to-treat approach. We will also conduct a per protocol sensitivity analysis: when clinicians in the
usual care group view EEG data, these patients will be included
in the guided group; and where there are technical difficulties
in viewing electroencephalogram data in the guided group, these
patients will be included in the blinded group. Patients who cannot be assessed for delirium will be excluded from the primary
outcome analysis. In two sensitivity analyses, these patients
(unless they die during surgery) will either all be assumed
to have had incident delirium or not to have had incident
delirium. We will compare preoperative characteristics between
respondents and alive non-respondents to 30-day postoperative
surveys. We will do the same for the 1-year postoperative surveys. Results will be presented with 95% CIs. All significance
testing will be two-sided, with P values <0.05 considered as
providing suggestive evidence and P values <0.005 as providing
more compelling evidence57. The statistical analyses will be performed with SAS, V.9.4 (SAS Institute, Cary, North Carolina)
and/or STATA, V.14.2 (StataCorp LP, College Station, Texas).

Secondary outcomes (falls, quality of life, psychiatric
status, cognitive functioning)
Estimations of the primary outcome (incidence of delirium)
was used for the calculation of the overall sample size of our
study. For secondary analyses, it is assumed that 80% (∼1000
patients) of the trial population will have completed the 30-day
and 1-year follow-up survey. With a sample size of 1000
patients, it should be possible to detect a difference of 0.5 points
(SD of 2.5) in mean score of the Physical Health Score from
baseline to 30-day and 1-year follow-up survey between the
usual care and guided group with a power of >80% and a
2-sided alpha level of p<0.05. Secondary outcomes and exploratory analyses will be examined in a number of ways; including
multivariable regressions.
Strengths of the study and limitations
Strengths. Several important strengths can be ascribed to the
ENGAGES-Canada study. The clinical trial is randomized,
pragmatic, includes high volume sites, and is conducted in
real life settings. The interventions to avoid EEG suppression are easily implemented and the primary outcome, the incidence of delirium, is of tremendous importance to patients,
health care systems and society. In relation to the primary outcome (delirium incidence), the CAM instrument has been
validated against reference standard DSM-IV and DSM-IVTR criteria in multiple studies, and has been appraised as one
of the two most reliable instruments for detecting delirium
in a research context58. The CAM long form has been
demonstrated to have excellent psychometric properties for both
hypoactive and hyperactive delirium59. Programmatic training,
coupled with the highly structured use of the CAM long form
(as we are doing in the trial), has demonstrated excellent interrater reliability of researchers28,60. In addition, by complementing the CAM long form (or CAM-ICU) with validated chart
review50, we are bolstering delirium detection and minimizing

missing primary outcome assessments. Since many components
of the study are already incorporated into existing processes
and infrastructures at participating Canadian sites, its implementation can be efficient. Enrollment is easily achieved within the
flow of the clinic. The study is largely conducted by anesthesiologists and is integrated into the course of their clinical
workday. Randomization is implemented in the operating room
at the point of patient care because the anesthesia protocols do
not require any advanced preparation or lead-in time. Enrollment
of vulnerable patients 60 years old and older allows us to
study a population that is understudied in clinical research.
The importance of studying and understanding this
targeted population lies in the potential of significant benefits
from reducing the incidence of postoperative delirium and its
related outcomes. Secondary outcomes such as patient-reported
health-related quality of life factors are especially relevant to
older patients who remain a largely understudied population.
Trial feasibility is enhanced by the participation of investigators
from multiple disciplines, who as a group has managed to establish a track record of successful collaboration and the completion of several major clinical trials (Canadian PACT group61–63).
Since EEG guidance of anesthesia is straightforward and inexpensive, positive results from the study could provide strong
effectiveness evidence, and would facilitate implementation,
sustainability and dissemination of the EEG-guided protocol
on a national level in Canada, as well as in other countries.
Limitations. Some limitations for the trial should be considered. The EEG-guided protocol can only be effective if
anesthesiologists adhere to it. Including patients in a clinical
trial aiming at the prevention of the incidence of postoperative delirium and providing patients and family members with
educational material on the subject could possibly decrease
the incidence of postoperative delirium. Three methods of
assessment will be used to diagnose postoperative delirium, a
pragmatic structured chart review, the full CAM and the CAMICU. The CAM-ICU has a decreased sensitivity compared
to the CAM long form. However, the CAM-ICU is broadly
used and has been validated for patients who are unable to
speak (i.e., with a tracheostomy or a breathing tube in place).
Available data from participating centers indicate that the vast
majority of patients enrolled in the in the study will be extubated
within the first 48 hours. As a result, delirium assessment will
usually be obtained with the more specific and sensitive instrument – the CAM long form. Since the 30-day and the 1-year
follow-ups for patient are based on self-report outcome measures,
a potential limitation is an incomplete follow-up at these periods in time. Consequently, a sensitivity analysis was performed
in our power calculations to take into account this possible
attrition (80% response rate at 30-day and at 1-year). We plan
to improve follow-up by contacting patients first by mail and, if
unsuccessful, by e mail or telephone calls. Postoperative delirium could be missed with recurrent assessments because it is
well known to be a fluctuating disorder. In our efforts to minimize missed diagnosis of postoperative delirium, we have
included a structured chart review. This validated complementary approach has been shown to increase the detection of
postoperative delirium49,50.
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Potential risks, alternatives and benefits
Benefits. If our hypotheses are confirmed, patients randomized into the group with the EEG-guided anesthesia will
have a greater chance of avoiding postoperative delirium and its
consequences’ downstream; including decrement in quality of
life, falls, and cognitive decline. Evaluation of any potential unanticipated negative effects of EEG-guidance by investigating this
range of psychiatric, cognitive, and functioning outcomes will also
be possible.
Risks. There are few risks associated with this study. Breach of
confidentiality is a rare risk. Psychiatric symptom self-report
measures may also cause patients temporary distress, but it may
also provide the opportunity for distressed patients to obtain
community mental health resources and/or appropriate referral.
EEG guidance of anesthesia poses a theoretical risk of intraoperative movement and/or awareness with recall. Nevertheless,
previous studies have not found an increased incidence of
awareness with randomization of patients to protocols using EEG
guidance of anesthesia14,15,64. In our study, intraoperative awareness with recall will be tracked within 48 hours of extubation
postoperatively with a modified Brice interview65 (see extended
data32). Review of adverse events by a data-safety monitoring
committee and the PI, in consultation with the institutional
review board, might lead to the recommendation to stop the trial
in the event of increased reporting of intraoperative awareness in
the EEG-guided group. In the informed consent for this study,
patients are made aware of the rare risk of intraoperative awareness with recall. Serious side effects will be reported to the
Ethics Committees and to the study’s data safety monitoring
board. There is no financial compensation for the participating
patients and all expenses related to the study are incurred by the
participating research sites.

Minimizing risks and confidentiality
Members of the research team will share protected and necessary health information. Confidentiality will be protected
by storing charts in locked cabinets located inside locked
research offices. Demographic information and electronic
data will be password-protected on an electronic database and
will be stored on the network drive of the participating sites.
Computers accessing this network will also be passwordprotected. This information will be entered by a designated
member of the research team. The documents and data used
for evaluation or statistical analyses will only contain coded
numbers. Patients are free to decline participation in the study
without penalties for the care they receive. Data management and
processing will be done by the Division of Biostatistics
Informatics Core at Washington University. Washington University is part of a consortium of institutional partners working to
provide clinical trial data and management of research through
a software toolset and workflow methodology for electronic
collection. REDCap (Research Electronic Data Capture) data
collection projects rely on a thorough study-specific data
dictionary defined in an iterative self-documenting process by
all members of the research team with planning assistance from
the Division of Biostatistics Informatics Core. A well-planned
data collection strategy for individual studies results from
an iterative development and testing process. REDCap servers are securely housed in an on-site limited access data center

managed by the Division of Biostatistics at Washington University. All web-based information transmission is encrypted. The
data is stored on a private network, firewall-protected. Individual
user identifiers and passwords are given to all users with restricted
access depending on the specific role in the study. REDCap was
developed specifically around HIPAA-Security guidelines, and
is implemented and maintained according to University guidelines. More than 500 academic and/or non-profit consortium are
supported by REDCap on 6 continents and 38,800 research
end-users.

Safety monitoring and adverse event reporting
Adverse events during the study will be monitored by the
research team. If a serious adverse event (SAE) occurs, it will
be directly reported to the REB in accordance with REB stipulations. For this pragmatic study, the safety monitoring plan seems
appropriate. We conducted three large clinical studies where
EEG-guided general anesthesia was given to half of the 28,000
patients studied. From these studies, no adverse events were
attributable to EEG-guided anesthesia14,15,64. There is therefore no reason to think that adverse events attributable to EEGguided anesthesia would occur in the present study. Since this
is a low risk trial, the study has an appropriate data and safetymonitoring plan. The Data Safety Monitoring Board (DSMB)
provides oversight of the ENGAGES-Canada Clinical Trial. The
DSMB will examine data for the safety of the participants and
will review the general conduct of the study66. Recommendations will be made by the DSMB regarding the modification,
continuation, or termination of the study67. The expertise of
the DSMB members will allow examination the cumulative
data, protection of the integrity of the clinical experiments to
which the patients have consented to participate, and to assure
the regulatory bodies and the public that conflicts of interest
do not compromise either patient safety or trial integrity68. An
annual review of the safety events will be conducted by the
DSMB. The DSMB may advise to stop the trial for safety concerns, but not for reasons of efficacy or because of futility66.
Implausibly large treatment effects are found in trials that stop
early for benefit, especially with small number of events69. Trials
that have terminated early show greater effect sizes compared
to trials that are continued, independent of existing statistical
rules for terminating the trial70.
Early stoppage of the trial. On average, we can assume that
patients in the group with EEG-guided anesthesia will receive,
on average, lower concentrations of inhaled anesthetic agents
during surgery. Studies using similar strategies have been reported
without increased incidents related to intraoperative awareness
with recall71,72. Nevertheless, we cannot exclude the possibility that patients receiving lower concentrations of inhaled
anesthetic agents could experience a higher incidence of intraoperative awareness. Therefore, it will be necessary to compare
the incidence of intraoperative awareness between groups
in the trial. We recommend to the DSMB that this occurs at
mid-point during the study (600 patients). Results from a
one-tailed comparison of the incidences of awareness between
the groups showing an increased incidence of awareness in
the EEG-guided group (with a p value <0.05) will result in
consideration by the DSMB to terminate the study. The severity of the awareness experiences; including reports of pain,
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paralysis, and distress could be taken into consideration by the
DSMB73. Furthermore, other measures of peritraumatic distress
and dissociation are administered at discharge, which will further
allow for an evaluation of severity of awareness. Besides
intraoperative awareness, a lower administration of inhaled
anesthetic agents is not hypothesized to result in adverse
outcomes that would be clinically important such as death,
myocardial infarction, and/or stroke. Other events that could
be associated with decreased anesthetic administration include
intraoperative patient movement and higher intraoperative blood
pressure and/or heart rate. These measures have unclear clinical
relevance if not related to more severe adverse events and, as
such, should not influence the decision to stop the study early.
It is recommended that an interim efficacy analysis of EEG
guidance should not be performed by the DSMB with respect
to the primary outcome of incident delirium. Some data support the hypothesis that EEG-guided anesthesia decreases
the incidence of postoperative delirium, but other data do not
support this hypothesis7,72,74,75. A higher incidence of postoperative delirium in the EEG-guided group would conflict with the
results of current studies. The results of a partially completed
trial would therefore be unlikely to provide compelling evidence to influence future clinical practice for anesthesia guided
by EEG waveform in this patient population.

Ethics and dissemination
All major changes to the protocol will be decided by the trial
steering committee. The committee will communicate these
changes to the REB and appropriate parties.
The final dataset of the trial is the property of the investigative
team and shall not be shared without permission from the principal investigator. Dissemination plans include presentations at
local, national and international scientific conferences. Every
effort will be made to publish results of the ENGAGES-Canada
trial in a peer-reviewed journal. Dissemination of results to study
participants and their family members will be available upon
request. Updates and results of the study will be available to the
public at www.clinicaltrials.gov.

Pre-specified additional analyses and sub-studies
Canadian centers participating in the ENGAGES-Canada
Trial are encouraged to develop sub-studies related to the trial
if approved by their local REBs. No sub-study can be published prior to pre-approval by the ENGAGES-Canada Trial
Management Committee.
a) A
 ssociation between delirium and clinically relevant
outcomes
The Engages-Canada trial will explore the associations between outcomes that are clinically relevant such
as cognitive decline, falls, functional decline, ICU and
hospital length of stay, and mortality; and the severity,
incidence, and duration of delirium.
b) D
 ifferences between observational and patient-reported
pain scores
Patients with postoperative delirium may lack the
ability to express verbally the level of pain they are

suffering76. Understanding that uncontrolled postoperative
pain may be related to delirium emphasizes the importance of the assessment and treatment of postoperative
pain. A comparison of behavioral pain assessment and
patient reported pain will be made in delirious and
non-delirious patients76. These pain scores can also be
explored in the context of psychiatric status as high
comorbidity rates exist.
c) P
 atient outcomes and delirium
The association between cognitive status, falls, and
quality of life with postoperative delirium will be
evaluated at 30-day and at 1-year post surgery.
d) A
 nesthesia depth and postoperative outcomes
Secondary measures, that can be related to the difference in anesthesia depth between the two groups of
patients, will be evaluated since patients in the EEGguided group will almost certainly be exposed to lower
concentrations of anesthetic agents. We will then be
able to compare our results with an ongoing randomized
clinical trial looking at the effects of depth of anesthesia on a range of outcomes77, such as cardiac arrest,
pulmonary embolus, death, stroke, myocardial infarction,
cardiac arrest, surgical site infection, ICU and hospital
length of stay, and intraoperative awareness.
e) Post-traumatic stress disorder (PTSD) outcomes
There is growing interest in understanding PTSD
post-operatively given its high prevalence in surgical
cohorts78. The current study allows for an incidence
investigation, as a history of PTSD is assessed at baseline. This study will allow for a thorough investigation
using contemporary DSM-5 PTSD criteria. Incident
PTSD at 30-day and at 1-year follow-up will be assessed
and several potential mechanisms can be explored
including: pre-operative factors, dissociation and
distress during the surgical period, delirium, surgical
complications, psychiatric and cognitive status, and depth
of anesthesia.
f) D
 ecreases in Regional Cerebral Oxygen Saturation and
EEG Suppression Patterns
Some of the participating sites measure Regional
Cerebral Oxygen Saturation (rSO2) on a regular basis.
Several studies have shown an association between
significant perioperative decreases in rSO2, cognitive
decline, and postoperative complications62,79,80. We
therefore intend to explore the relationship between EEG
suppression and cerebral desaturations.

Study status
To date two interim analyses have been performed, one at
240 patients and another at 570 patients. While randomization
remains blinded, both analyses confirmed separation of the
groups in term of total time in EEG suppression pattern
(control group with more suppression) as well as a total incidence
of delirium within the range of the predicted value used for the
original power analysis.
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Strengths
• T
 he ENGAGES-Canada study is a multi-center clinical trial, conducted with a pragmatic design to reflect the
clinical setting encountered in real-life.

This project contains the following extended data:
• ENGAGES-CANADA Protocol Appendix.pdf (PDF
file containing all study questionnaires and screening
materials)

• C
 ardiac surgery patients are at high risk for postoperative
delirium.

• E
 NGAGES-CANADA Script.pdf (script for research
assistants to introduce the psychiatric symptom measures)

• P
 ostoperative delirium is important to patients, healthcare
providers, and society.

• E
 NGAGES-CARDIAC Conscent French.pdf (Consent
form, French)

• G
 uidance of anesthesia by electroencephalography is
low-cost and could be broadly accepted.
• A
 s a secondary aim, this study will also include cognitive and psychiatric outcomes 30-days and 1-year after
surgery.

Limitations
• T
 he protocol-guiding anesthesia with electroencephalography can only be effective if anesthesiologists adhere
to it.
• D
 elirium is a disorder that fluctuates in the course of 24
hours. It can be easily missed with scheduled assessments,
regardless of the rigor of these assessments.
• W
 hen patients are unable to speak, delirium assessment
might be less sensitive.
• I ncomplete follow-up at 30 days and 1-year postoperatively
might limit some of the interpretations.
• S
 elf-reported cognitive and psychiatric symptom measures
are less reliable than structured clinical interviews.

Data availability
Underlying data

• E
 NGAGES-CARDIAC Consent English.pdf (Consent
form, English)

Reporting guidelines
Open Science Framework: SPIRIT 2013 checklist for ‘Protocol
for the electroencephalography guidance of anesthesia to alleviate geriatric syndromes (engages-Canada) study: A pragmatic,
randomized clinical trial’, https://doi.org/10.17605/OSF.IO/
DXY2732
Data are available under the terms of the Creative Commons
Zero “No rights reserved” data waiver (CC0 1.0 Public domain
dedication).
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